Sano blog | Patrick Short, PhD (6)

rare disease genetic testing podcast recap

Podcast recap: Pioneering tRNA therapies with Michelle Werner

In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had a fascinating conversation with Michelle Werner, CEO of Alltrna and CEO/Partner at Fla...

precision medicine podcast recap

The Genetics Podcast recap: Exploring the microbiome's influence on personalised medicine with Almut Heinken

In the latest episode of The Genetics Podcast, Sano CEO Patrick Short had the pleasure of speaking with Almut Heinken, a junior professor at the INSERM Institut...

rare disease genetic testing

Exploring natural history studies in drug development

Natural history studies are vital for understanding disease progression, particularly in rare diseases. They provide a baseline to evaluate the effectiveness of...

precision medicine rare disease genetic testing

Newborn genome sequencing: Benefits, risks, and ethics

Children born with rare inherited conditions often face a protracted diagnostic odyssey before the cause of their illness is identified. This delay is costly, s...

biomarkers precision medicine genetic testing

From genome to bedside: Dr. Andrea Gropman on how genetics is transforming modern medical practice

In the informative webinar hosted by Dr. Patrick Short, Co-founder and CEO of Sano Genetics, guest Dr. Andrea Gropman explored the profound impact of genetics a...

precision medicine rare disease

Natural history studies: Disease progression and trial design

Natural history studies are instrumental in advancing precision medicine by offering a nuanced understanding of the patient journey across various diseases, inc...

biomarkers precision medicine genetic epidemiology

Webinar recap: Understanding complex disease biology – Insights into the genetics of long COVID

This webinar, co-hosted by Sano Genetics and PrecisionLife, highlighted the complex nature of long Covid, which affects up to 30% of Covid-19 survivors and pres...

genetic testing MASLD liver disease

World Liver Day spotlight: Pioneering genetic solutions for liver disease

Liver disease remains one of the leading causes of morbidity and mortality worldwide, presenting complex challenges in healthcare due to its multifaceted nature...

precision medicine rare disease

AI in drug development: What breaks from data to trials

Drug development remains one of the most resource-intensive and failure-prone processes in healthcare. Traditional approaches depend heavily on trial-and-error ...

biomarkers precision medicine rare disease

How natural history studies support rare disease drug development

Natural history studies document disease progression by observing diseases in their unmodified state, deepening our understanding of how conditions evolve over ...

Clinical research blog